MedPath

mTBI Identification and Monitoring Through Retinal Scanning

Recruiting
Conditions
Brain Injuries, Traumatic
Interventions
Device: Head and Intraocular Trauma Tool
Registration Number
NCT06142435
Lead Sponsor
Rebiscan, Inc.
Brief Summary

Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 60 TBI patients and 20 controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Age 18-45 years

  2. Presents to the facility within 2 weeks of head trauma

  3. Able to provide informed consent

    • If minor, then able to provide parental consent and minor consent
  4. Able to participate in the examination, including the ability to follow simple instructions

  5. Fluency in English or Spanish

Exclusion Criteria
  1. Glasgow Coma Scale score equal to or less than 13 at the time of study enrollment
  2. Under the influence of alcohol or drugs
  3. Previous eye surgery
  4. Visual acuity known to be 20/200 or less in either eye
  5. Known strabismus, amblyopia (lazy eye), or double vision
  6. Known eye movement disorder, including nystagmus
  7. Known optic nerve disease, including papilledema or optic neuropathy
  8. Known retinal disease, including macular degeneration or retinal degeneration
  9. Known cataract
  10. History of neurosurgery
  11. History of stroke/brain hemorrhage, brain tumor, or epilepsy
  12. Any head trauma requiring medical attention from a physician within the last 6 months
  13. Diagnosed dementia or cognitive impairment requiring assistance for daily living
  14. Other condition(s) under the care of a neurologist
  15. Psychiatric hospitalization in the last 90 days
  16. Subject considered unsuitable for participation in this clinical trial by PI, treating clinician, or study research staff
  17. Any minor brain injury regardless of loss of consciousness

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TBI-Suspected PatientsHead and Intraocular Trauma ToolTBI participants 18-45 years of age, recruited from patients at a clinical research facility who present with head trauma. Clinical evaluation for the patient can be positive (target condition present) or negative (target condition absent) for mTBI. Testing will occur on Day-0, Day-14, and Day-30.
ControlsHead and Intraocular Trauma ToolParticipants should not be part of the Intended Use Population. Subjects that present to the hospital, clinic, or emergency department, either as a patient or non-patient, with no history of head trauma and, are 18-45 years of age.
Primary Outcome Measures
NameTimeMethod
TBI Detection1 day

Patients who present with suspected TBI to the clinic will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI.

Secondary Outcome Measures
NameTimeMethod
TBI Monitor30 days

Patients who present with suspected TBI to the clinic and had initially been tested for TBI detection will receive a second set fo scans at one month to identify whether the HITT device can accurately identify patients with TBI.

Trial Locations

Locations (1)

Boston Medical Center Concussion Clinic, Ryan Center for Sports Medicine & Rehabilitation at Boston University

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath